TD:Q1/F24 FIRST LOOK: SOLID Q1; MARGINS/ LEVERAGE IMPROVEThe Q1 results were in-line despite some patients who qualify for the CDCP deferring appointments until their coverage commences. Q2 guidance was generally in-line and likely impacted by the same dynamic, with the CDCP launching this month, with little/no impact expected for the full year. Margins increased and net debt/leverage declined, which we believe investors will view positivel